BPO
Click for more information
0.00% 0.3¢ bioprospect limited

Ann: Trading Halt , page-4

  1. remote
    456 Posts.
    lightbulb Created with Sketch. 33
    clock Created with Sketch.
    07/08/13
    12:44
    Post #: 12165701
    Actually looks like the new management might not be totally bad. Quite a reasonable outcome.

    Now can they get a decent biotech deal while the sector is hot and give us suffering shareholders some hope.
    BPO Price at posting: 0.1¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BPO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.